DEA: These steroids should be exempt
DEA is designating six pharmaceutical products as exempt anabolic steroids under the Controlled Substances Act. The reason is that these six products are similar to other preparations that have already been exempted.
DEA: These steroids should be exempt
DEA is designating six pharmaceutical products as exempt anabolic steroids under the Controlled Substances Act. The reason is that these six products are similar to other preparations that have already been exempted. The six products include various dosages of esterified estrogens and methyltestosterone from Interpharm Inc., Lannett Co., and ANDAPharm LLC. DEA published this interim rule in the Sept. 1 Federal Register. Stating that the rule is effective as of Sept. 1, the FDA nevertheless said it seeks comments, which should reach the agency by Oct. 31.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
